Identification of Acyl-Protein Thioesterase-1 as a Polysorbate-Degrading Host Cell Protein in a Monoclonal Antibody Formulation Using Activity-Based Protein Profiling

被引:2
|
作者
Sprager, Ernest [1 ,2 ]
Moeller, Jens [3 ]
Lin, Yuhsien [3 ]
Reisinger, Veronika [3 ]
Bratkovic, Tomaz [1 ]
Lunder, Mojca [1 ]
Vasl, Jozica [2 ]
Krajnc, Aleksander [2 ]
机构
[1] Univ Ljubljana, Fac Pharm, Ljubljana, Slovenia
[2] Novartis Pharmaceut Mfg LLC, Novartis Tech Res & Dev, Biol Tech Dev Menge, Ljubljana, Slovenia
[3] Novartis Pharmaceut Mfg GmbH, Novartis Tech Res & Dev, Analyt Characterizat, Kundl, Austria
关键词
Antibody drug(s); Enzyme(s); Protein formulation(s); Hydrolysis; Liquid Chromatography-Mass spectrometry (LC-MS); Monoclonal antibody(s); Surfactant(s); B-LIKE; 2; SERINE HYDROLASES; DEGRADATION; PROTEOMICS; PRODUCTS; IMPACT; HCPS; INHIBITION; HYDROLYSIS; STABILITY;
D O I
10.1016/j.xphs.2024.05.013
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Polysorbate (PS) degradation in monoclonal antibody (mAb) formulations poses a significant challenge in the biopharmaceutical industry. PS maintains protein stability during drug product's shelf life but is vulnerable to breakdown by low-abundance residual host cell proteins (HCPs), particularly hydrolytic enzymes such as lipases and esterases. In this study, we used activity-based protein profiling (ABPP) coupled with mass spectrometry to identify acyl-protein thioesterase-1 (APT-1) as a polysorbate-degrading HCP in one case of mAb formulation with stability problems. We validated the role of APT1 by matching the polysorbate degradation fingerprint in the mAb formulation with that of a recombinant APT1 protein. Furthermore, we found an agreement between APT1 levels and PS degradation rates in the mAb formulation, and we successfully halted PS degradation using APT1-specific inhibitors ML348 and ML211. APT1 was found to co-purify with a specific mAb via hitchhiking mechanism. Our work provides a streamlined approach to identifying critical HCPs in PS degradation, supporting quality-by-design principles in pharmaceutical development. (c) 2024 The Authors. Published by Elsevier Inc. on behalf of American Pharmacists Association. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)
引用
收藏
页码:2128 / 2139
页数:12
相关论文
共 50 条
  • [31] The Clinical and Pathologic Features according to Expression of Acyl Protein Thioesterase-1 (APT1) in Stage I Non-small Cell Lung Cancer
    Shin, Jung Ar
    Lee, Chang Ryul
    Byun, Min Kwang
    Chang, Yoon Soo
    Kim, Se Kyu
    Chang, Joon
    Ahn, Chul Min
    Kim, Hyung Jung
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2010, 68 (04) : 212 - 217
  • [32] Kinases in lung squamous cell carcinoma and inhibitor matching using quantitative activity-based protein profiling
    Fang, Bin
    Wood, Elizabeth R.
    Li, Jiannong
    Chen, Y. Ann
    Brantley, Stephen G.
    Kinose, Fumi
    Guan, Wei
    Myers, Andrew R.
    Eschrich, Steven A.
    Haura, Eric B.
    Koomen, John M.
    CANCER RESEARCH, 2014, 74 (19)
  • [33] Identification and Characterization of Host Cell Protein Product-Associated Impurities in Monoclonal Antibody Bioprocessing
    Levy, Nicholas E.
    Valente, Kristin N.
    Choe, Leila H.
    Lee, Kelvin H.
    Lenhoff, Abraham M.
    BIOTECHNOLOGY AND BIOENGINEERING, 2014, 111 (05) : 904 - 912
  • [34] Comparative Analysis of Click Chemistry Mediated Activity-Based Protein Profiling in Cell Lysates
    Yang, Yinliang
    Yang, Xiaomeng
    Verhelst, Steven H. L.
    MOLECULES, 2013, 18 (10) : 12599 - 12608
  • [35] Development and Application of a Chemical Probe Based on a Neuroprotective Flavonoid Hybrid for Target Identification Using Activity-Based Protein Profiling
    Gunesch, Sandra
    Soriano-Castell, David
    Lamer, Stephanie
    Schlosser, Andreas
    Maher, Pamela
    Decker, Michael
    ACS CHEMICAL NEUROSCIENCE, 2020, 11 (22): : 3823 - 3837
  • [36] Knockout of a difficult-to-remove CHO host cell protein, lipoprotein lipase, for improved polysorbate stability in monoclonal antibody formulations
    Chiu, Josephine
    Valente, Kristin N.
    Levy, Nicholas E.
    Min, Lie
    Lenhoff, Abraham M.
    Lee, Kelvin H.
    BIOTECHNOLOGY AND BIOENGINEERING, 2017, 114 (05) : 1006 - 1015
  • [37] A Multiplexing Activity-Based Protein-Profiling Platform for Dissection of a Native Bacterial Xyloglucan-Degrading System
    McGregor, Nicholas G. S.
    de Boer, Casper
    Foucart, Quentin P. O.
    Beenakker, Thomas
    Offen, Wendy A.
    Codee, Jeroen D. C.
    Willems, Lianne I.
    Overkleeft, Herman S.
    Davies, Gideon J.
    ACS CENTRAL SCIENCE, 2023, 9 (12) : 2306 - 2314
  • [38] Plasma Protein Turnover Rates in Rats Using Stable Isotope Labeling, Global Proteomics, and Activity-Based Protein Profiling
    Smith, Jordan Ned
    Tyrrell, Kimberly J.
    Hansen, Joshua R.
    Thomas, Dennis G.
    Murphree, Taylor A.
    Shukla, Anil
    Luders, Teresa
    Madden, James M.
    Li, Yunying
    Wright, Aaron T.
    Piehowski, Paul D.
    ANALYTICAL CHEMISTRY, 2017, 89 (24) : 13559 - 13566
  • [39] Activity-based protein profiling in bacteria: Applications for identification of therapeutic targets and characterization of microbial communities
    Keller, Laura J.
    Babin, Brett M.
    Lakemeyer, Markus
    Bogyo, Matthew
    CURRENT OPINION IN CHEMICAL BIOLOGY, 2020, 54 : 45 - 53
  • [40] Identification of Target Pathways Induced By the Multiple Myeloma Tumor Microenvironment Using Activity-Based Protein Profiling and Ex Vivo Protein Kinase Inhibitor Screening
    Meads, Mark B.
    Oliveira, Paula
    Distler, Allison
    Silva, Maria
    Burger, Karen
    Fang, Bin
    Collins, Aunshka
    Cleveland, John L.
    Koomen, John M.
    Silva, Ariosto
    Rebatchouk, Dmitri
    Shain, Kenneth H.
    Roush, William R.
    BLOOD, 2016, 128 (22)